FDA approves non-opioid pain medication dubbed possible medical ‘game changer’
The Food and Drug Administration (FDA) is hoping a newly approved non-opioid pain medication could help save lives. Dr. Jianguo Cheng, from the Cleveland Clinic, constantly works with patients with acute pain.
New FDA-approved painkiller could soon hit Chattanooga pharmacy shelves
A new painkiller was approved by the Food and Drug Administration (FDA) on Thursday, and is one step closer to making its way to pharmacy shelves in the Chattan
FDA approves a new pain med that could eliminate addiction. When can GA patients get it?
The opioid epidemic continues to affect hundreds of thousands of people, but there may be hope for the future with a new, non-addictive alternative.
FDA approves opioid-free pain medication with 'no sign of addiction'
A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients. Doctors share what patients should know about the drug.
FDA Approves the First Non-Opioid Pain Medicine in 20 Years
On Jan. 30, the U.S. Food and Drug Administration (FDA) approved a new drug called suzetrigine to treat moderate-to-severe pain. The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals,
FDA Approves New Non-Opioid Painkiller Journavx for Acute Pain | Watch
The United States Food and Drug Administration (FDA) has approved a new non-opioid prescription medication, Journavx (suzetrigine), for adults with moderate to severe acute pain. Developed by Vertex Pharmaceuticals,
FDA approves Vertex non-opioid pain drug
The FDA's approval of the non-addictive painkiller Journavx last week marked a milestone in the field of pain management. Why it matters: Millions of Americans with acute and chronic pain are prescribed opioids,
FDA Approves First-in-Class Non-Opioid Pain Drug Journavx
The U.S. Food and Drug Administration (FDA) has approved Journavx (suzetrigine) 50 milligram oral tablets, a groundbreaking non-opioid analgesic designed to treat moderate to severe acute pain
Gulf Shores pharmacist sees promise in FDA-approved nonaddictive pain medicine Journavx
For the first time in more than 25 years, the U.S. Food and Drug Administration has signed off on a new type of pain reliever.The newly app
Hosted on MSN4h
Celltrion’s Avtozma receives FDA approval for multiple conditions
The FDA's approval is grounded in an evidence totality and comprehensive data package, which includes outcomes from a study.
Recall for broccoli sold at Walmart in 20 states upgraded to highest risk level: FDA
The Food and Drug Administration has upgraded its classification of a broccoli recall initially reported in late December, ...
Chocolate recall: FDA warns about potentially deadly treats
On Dec. 12, 2024, Cal Yee Farm, a California-based company, announced a recall on a variety of products, including dark ...
JD Supra5h
How New Executive Orders May Affect FDA’s Medical Device Operations
Several executive orders recently signed by US President Donald Trump may have significant implications for the US Food and Drug Administration ...
FDA Greenlights Studies of Pig Kidney Transplants in Humans
The US Food and Drug Administration approved clinical trials that will transplant organs from genetically modified pigs into ...
Insurer Denies Access To Drugs Granted Accelerated Approval By FDA
Going forward, we may see more instances in which insurers deny or (temporarily) severely restrict coverage of accelerated ...
New guidelines for lead in baby food set low standards, but not enforceable
After repeated calls for action, the FDA has set a guideline for lead in baby food -- but it is not the end of the fight for ...
Why Some Food Additives Banned in Europe Are Still on U.S. Shelves
In the U.S., it’s still found in many confections, including Sour Patch Kids watermelon candies, Hostess chocolate cupcakes ...
Broccoli and chocolate, fish and chips: Class 1 recalls for products sold in Oregon
The (FDA) has announced several Class 1 recalls, the highest risk level, for various food products sold across multiple ...